Pichl Daniel's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Feb 5, 2024
- Accession no.
- 0001104659-24-010826
- Filed
- Feb 5, 2024
- Trade date
- Feb 2, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.16M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pichl DanielCIK 0001819465 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock | MOption exerciseAcquired | +16,250 | $27.64 | +$449,150 | 71,393 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −9,266 | $43.81 | −$405,943.46 | 62,127 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −14,175 | $44.31 | −$628,094.25 | 47,952 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −1,997 | $45.95 | −$91,762.15 | 45,955 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −743 | $46.44 | −$34,504.92 | 45,212 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock | MOption exerciseDisposed | −16,250 | $0.00 | $0 | 48,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.